A Comparison of Ceftriaxone and Cefuroxime for the Treatment of Bacterial Meningitis in Children

New England Journal of Medicine

Volumn 322, Issue 3, 1990, Pages 141-147

  Schaad, Urs B ^a   Suter, Susanne ^c   Gianella Borradori, Athos ^b   Pfenninger, Juerg ^a   Auckenthaler, Raymond ^c   Bernath, Otto ^a   Cheseaux, Jean Jacques ^b   Wedgwood, Joanna ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CEFUROXIME;

ARTICLE; BACTERIAL MENINGITIS; CHILD; DRUG SENSITIVITY; ECHOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0025174837     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199001183220301     Document Type: Article

References (29)

1. Schaad UB. Treatment of bacterial meningitis. Eur J Clin Microbiol Infect Dis 1986; 5: 492–7.
2. Johansson Ö, Cronberg S, Hoffstedt B, et al. Cefuroxime versus ampicillin and chloramphenicol for the treatment of bacterial meningitis: report from a Swedish study group. Lancet 1982; 1: 295–9.
3. Marks WA, Stutman HR, Marks MI, et al. Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial. J Pediatr 1986; 109: 123–30.
4. Del Rio MA, Chrane D, Shelton S, McCracken GH Jr, Nelson JD. Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children. Lancet 1983; 1: 1241–4.
5. Barson WJ, Miller MA, Brady MT, Powell DA. Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children. Pediatr Infect Dis 1985; 4: 362–8.
6. Jacobs RF, Wells TG, Steele RW, Yamauchi T. A prospective randomized comparison of cefotaxime vs ampicillin and chloramphenicol for bacterial meningitis in children. J Pediatr 1985; 107: 129–33.
7. Rodriguez WJ, Puig JR, Khan WN, Feris J, Gold BG, Sturla C. Ceftazidime vs. standard therapy for pediatric meningitis: therapeutic, pharmacologic and epidemiologic observations. Pediatr Infect Dis 1986; 5: 408–15.
8. Kaplan SL, Mason SK, Mason EO Jr, Murphy M, Smith EO. Follow-up of prospective randomized trial of ampicillin or chloramphenicol versus moxalactam treatment of Haemophilus influenzae type b meningitis. J Pediatr 1988; 112: 795–8.
9. Lebel MH, Freij BJ, Syrogiannopoulos GA, et al. Dexamethasone therapy for bacterial meningitis: results of two double-blind, placebo-controlled trials. N Engl J Med 1988; 319: 964–71.
10. Lebel MH, Hoyt MJ, Waagner DC, Rollins NK, Finitzo T, McCracken GH Jr. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. Am J Dis Child 1989; 143: 301–6.
11. Lebel MH, McCracken GH Jr. Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children. Pediatrics 1989; 83: 161–7.
12. Lebel MH, Hoyt MJ, McCracken GH Jr. Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis. J Pediatr 1989; 114: 1049–54.
13. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. Document M7-A. Villanova, Pa.: National Committee for Clinical Laboratory Standards, 1985.
14. Schoenknecht FD, Sabath LD, Thornsberry C. Susceptibility tests: special tests. In: Lennette EH, Balows A, Hausler WJ Jr. Shadomy HJ, eds. Manual of clinical microbiology. 4th ed. Washington, D.C.: American Society for Microbiology, 1985:1000–8.
15. Matthews DE, Farewell VT, eds. Using and understanding medical statistics. New York: Karger, 1985:1–200.
16. Schaad UB, Wedgwood-Krucko J, Tschaeppeler H. Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet 1988; 2: 1411–3.
17. Steele RW, Bradsher RW. Comparison of ceftriaxone with standard therapy for bacterial meningitis. J Pediatr 1983; 103: 138–41.
18. Bryan JP, Rocha H, da Silva HR, Taveres A, Sande MA, Scheld WM. Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis. Antimicrob Agents Chemother 1985; 28: 361–8.
19. Congeni BL, Bradley J, Hammerschlag MR. Safety and efficacy of once daily ceftriaxone for the treatment of bacterial meningitis. Pediatr Infect Dis 1986; 5: 293–7.
20. Schaad UB, Krucko J, Pfenninger J. An extended experience with cefuroxime therapy of childhood bacterial meningitis. Pediatr Infect Dis 1984; 3: 410–6.
21. Wilson HD, Haltalin KC. Ampicillin in Haemophilus influenzae meningitis: clinicopharmacologic evaluation of intramuscular vs. intravenous administration. Am J Dis Child 1975; 129: 208–15.
22. Tanner DJ, Nazarian MQ. Cost containment associated with decreased parenteral antibiotic administration frequencies. Am J Med 1984; 77: 104–11.
23. Arditi M, Herold BC, Yogev R. Cefuroxime treatment failure and Haemophilus influenzae meningitis: case report and review of literature. Pediatrics 1989; 84: 132–5.
24. Machka K, Braveny I, Dabernat H, et al. Distribution and resistance patterns of Haemophilus influenzae: a European cooperative study. Eur J Clin Microbiol Infect Dis 1988; 7: 14–24.
25. Baumgartner ET, Augustine A, Steele RW. Bacterial meningitis in older neonates. Am J Dis Child 1983; 137: 1052–4.
26. Pigrau C, Pahissa A, Gropper S, Sureda D, Martinez Vazquez JM. Ceftriaxone-associated biliary pseudolithiasis in adults. Lancet 1989; 2: 165.
27. Lee SP, Maher K, Nicholls JF. Origin and fate of biliary sludge. Gastroenterology 1988; 94: 170–6.
28. Dodge PR, Davis H, Feigin RD, et al. Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med 1984; 311: 869–74.
29. Kaplan SL, Catlin FI, Weaver T, Feigin RD. Onset of hearing loss in children with bacterial meningitis. Pediatrics 1984; 73: 575–8.